TITLE

Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery

AUTHOR(S)
Belboul, A.; Al-Khaja, N.
PUB. DATE
December 1997
SOURCE
Perfusion;1997, Vol. 12 Issue 6, p385
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To evaluate whether the effect of heparin coating the extracorporeal circuit resulted in differences in patient outcome and haemostatic alteration, 24 patients undergoing elective, isolated coronary artery bypass were randomized prospectively to cardiopulmonary bypass (CPB) with heparin-coated circuits (group H, n = 12) or uncoated circuits (group C, n = 12). The technique of CPB, heparinization and its reversal were the same in both groups. We studied complement status (C3d, C3, C3d/C3, C4 and C-function), white blood cell counts with differentiation and the postoperative morbidity. The results confirmed that CPB activates complement and increases neutrophils in both the H and C groups. A significantly lower level of Ieucocytosis was seen in group H compared to the C group (p < 0.05). The complement function via the classical pathway (C-function), expressed as a percentage of the function of a reference serum pool (the values of normal sera were 75--125%), was significantly reduced in both heparin-coated and uncoated circuits (p < 0.05). There was no significant intergroup difference regarding C3, C3d/C3, C4 and C- function during the study period. A lower frequency of postoperative morbidity was present in the H group. We conclude that heparin-coated surfaces elicit less leucocytosis and decrease postoperative morbidity in patients undergoing cardiac surgery but do not cause a significant difference regarding activation of the complement system as reported by many other investigators.
ACCESSION #
7392816

 

Related Articles

  • Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory response. Thiara, A. S.; Andersen, V. Y.; Videm, V.; Mollnes, T. E.; Svennevig, K.; Hoel, T. N.; Fiane, A. E. // Perfusion;Jan2010, Vol. 25 Issue 1, p9 

    Background: The biocompatibility of cardiopulmonary bypass surfaces has been improved by heparin and polymer surface modifications. The present study compared the effect of two such coatings on the inflammatory reactions after open heart surgery. Methods: Thirty patients undergoing elective...

  • Heparin-bonded circuits without a cardiotomy: a description of a minimally invasive technique of cardiopulmonary bypass. Lilly, Kevin J; O'Gara, Paul J; Treanor, Patrick R; Crowley, Richard; Reardon, Deborah L; Shapira, Oz M; Khuri, Shukri F; Aldea, Gabriel S; Shemin, Richard J // Perfusion;Mar2002, Vol. 17 Issue 2, p95 

    The deleterious effects of cardiotomy suction have been well recognized and well documented for some time. The use of cardiotomy suction results in the exposure of blood to the defoaming sock, aspiration of stagnant pericardial blood into the systemic circulation, and the entrainment of both...

  • Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part I - the effects of heparin, protamine and propofol. Gao, F.; Harris, D.; Sapsed-Bryne, S.; Sharp, S. // Perfusion;1997, Vol. 12 Issue 3, p163 

    Neurone-specific enolase (NSE) and Sangtec 100 (S-100) (Sangtec Medical, Sweden) assays are designed for clotted samples, but when studying cerebral damage following cardiac surgery, perioperative samples will contain heparin and/or protamine. The lipid emulsion propofol is also frequently used...

  • Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. Wendel, H.P.; Scheule, A.M.; Eckstein, F.S.; Ziemer, G. // Perfusion;1999, Vol. 14 Issue 1, p21 

    Extracorporeal circulation (ECC) in paediatric patients with heparin-coated oxygenation systems is rarely investigated. The objective of this study was to evaluate, preclinically, the haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. We compared 16 paediatric...

  • Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Ranucci, M.; Isgrο, G.; Cazzaniga, A.; Soro, G.; Menicanti, L.; Frigiola, A. // Perfusion;1999, Vol. 14 Issue 6, p437 

    Heparin resistance (HR) is a common event in cardiac operations. At present, no clear recognition of the risk factors for HR has been reached. The aim of this study was to determine a predictive model for HR, based on the preoperative patient's profile. Two hundred consecutive patients scheduled...

  • Heparin monitoring during cardiac surgery. Part 2: calculating the overestimation of heparin by the activated clotting time. Raymond, P.D.; Ray, M.J.; Callen, S.N.; Marsh, N.A. // Perfusion;Sep2003, Vol. 18 Issue 5, p277 

    Activated clotting time (ACT) values were converted to heparin concentration, enabling an assessment of the accuracy of the ACT and a quantification of the prolongation imposed by bypass. Blood samples were obtained from 42 adult cardiopulmonary bypass (CPB) patients before and during bypass...

  • Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time. Raymond, P.D.; Ray, M.J.; Callen, S.N.; Marsh, N.A. // Perfusion;Sep2003, Vol. 18 Issue 5, p269 

    There is limited published data on the agreement between techniques for monitoring heparin levels. The aim of this study was to validate the Hepcon/HMS, with particular focus on the agreement with laboratory anti-Xa assay. The performances of two ACT instruments - Hemochron and HemoTec - were...

  • Different patterns of heparin resistance: therapeutic implications. Ranucci, M; Isgrò, G; Cazzaniga, A; Ditta, A; Boncilli, A; Cotza, M; Carboni, G; Brozzi, S // Perfusion;May2002, Vol. 17 Issue 3, p199 

    Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III....

  • Danaparoid-sodium/heparin.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p105 

    An abstract of the article "Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery" by T. Ronchard and others is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics